①The market capacity is gradually increasing

Related research by the National Development and Reform Commission shows that by 2020, China's urbanization level will reach 58.5%. Urbanization will inevitably drive consumption growth, and the consumption concepts and consumption needs of new citizens will undergo qualitative changes. Therefore, there is a huge consumption space for safer, more reliable and more comfortable disposable sterile medical polymer products. With the continuous improvement of people's living standards, the continuous enhancement of health awareness, the deepening of urbanization and the increase of the proportion of aging, the market scale of disposable medical polymer products will continue to grow.

In recent years, the continuous deepening of the reform of China's medical and health system and the continuous deepening of the reform of the medical system have laid a solid foundation for the realization of a universal medical security system in the year. The improvement of the medical system stimulates the market demand for disposable medical polymer products.

In addition, with the development of the country’s prevention and control measures for epidemics and infectious diseases, as well as economic and social development, due to changes in the living environment and people’s living habits, the incidence of some non-communicable diseases has begun to rise sharply, which is expected to lead to an increase. The rapid growth in market demand for sexual medical polymer products provides a broad growth space for disposable medical products manufacturers.

②The integration and upgrading of domestic industries is an inevitable trend

Although the total market of disposable polymer medical products in China continues to grow, the products are mainly concentrated in low-end popular products, and the benefits are not obvious. Domestic manufacturers of single-use sterile medical polymer products have serious homogeneity and low-level production. They are prone to form a vicious competition dominated by price wars. Some companies even occupy the market with prices below or close to cost. This short-sighted behavior is not conducive to the long-term development of the industry. At present, China's disposable medical polymer products industry still has a large number of family-type and workshop-type production enterprises. These enterprises have the characteristics of low scale and technical level, uneven production qualifications, poor production environment, and product quality and after-sales service cannot be guaranteed. . As labor costs and raw material prices continue to rise, and the upgrading of the industrial structure deepens, some manufacturing companies that cannot form scale effects, production qualifications, and poor technical levels will lose their competitive advantage in the market. In addition, other emerging market countries such as Brazil, India and other countries in the same industry bring external pressure and challenges cannot be ignored.

Therefore, in the future competition in the disposable medical polymer products industry, on the one hand, companies need to improve the competitive advantage of their products, and improve the grade of products through the application of new materials and new technologies, the improvement of product quality standards, and the improvement of processing techniques. , Jumping out of the homogeneous competition situation that hovered at the level of low-grade products. On the other hand, domestic production enterprises are many and small in scale, but according to the overall layout, the production areas are still relatively concentrated. This suggests that if enterprises can establish orderly competition and reasonable division of labor between enterprises, the large-scale development of a single product is proposed. Higher requirements. In the future, manufacturers of disposable polymer medical products will not only need to reduce production costs by gaining economies of scale, but also need to establish a medical consumables industrial base to strengthen leading products, improve product reliability, safety, and strengthen services for future development. Orientation is conducive to improving the differentiated competitiveness of enterprises and the bargaining power in the market.

③Improving the added value of products is the trend of industry development

Traditional disposable sterile medical polymer products usually use their own physical properties to play the role of anti-bacterial, anti-infection and alleviation of patient suffering during treatment, surgery or nursing. These properties mainly depend on the physical properties and the materials used. The control of the production process is reached. With the development of clinical medicine, combining drugs with traditional medical polymer products is an important trend in the development of disposable sterile medical polymer products industry. For example, in wound and wound care, dressings with trace elements that have a targeted repair effect on damaged cells and promote cell regeneration, such as alginate biological dressings and other medical ingredients that have just entered the field of clinical application Dressing, etc. Compared with traditional dressings, this kind of dressing not only plays the traditional role of creating a sterile environment for the wound and preventing wound infection, but also promotes the regeneration of epithelial cells, inhibits the overgrowth of granulation tissue, and ultimately reduces the scar and promotes the wound. Healing effect. As people’s requirements for treatment and care continue to increase, industry competition continues to intensify, and companies’ strong desire to differentiate competition and break the current low-quality and homogeneous competition in the market, this kind of treatment is comparable to medical products. The practice of combining to enhance the added value of products will become an important trend in the future development of the disposable sterile medical products industry.

④Integrate circulation links and reduce circulation costs

The price of medical devices is falsely high, and the problem is not mainly in the production link, but the false high part is mainly caused in the circulation link. Generally speaking, from a manufacturer to a hospital, medical consumables usually go through multiple levels, such as first-level agents, regional agents, and provincial-level agents, and each transfer has at least a 30% profit bonus.

According to the survey report of the Guangdong Provincial Price Bureau, 89% of the hospitals surveyed mainly purchase medical consumables from wholesale companies, and 11% of the hospitals purchase medical consumables from wholesale companies and manufacturing companies at the same time, that is, the vast majority of medical consumables. It has to go through the intermediate link of wholesalers, and the price increase rate and the price increase range in the circulation field lack effective supervision. At the same time, the report shows that in the intermediate circulation, high-value medical consumables in Guangdong Province are generally sold to patients from the factory (or imported) to medical institutions, with an average price increase of 2-3 times, and individual products even more than ten times. These medical consumables have been changed hands several times, and the prices have been increased layer by layer. As a result, the falsely high prices have seriously harmed the interests of patients (Source: Guangdong Provincial Price Bureau "Medical Consumables Price Research Report" (2011)).

Starting from entering the disposable medical products industry, the issuer has begun to build a nationwide sales platform and medical logistics network, and directly establish supply relationships with major hospitals in various regions. Through a wide-ranging sales network, the problem of inflated prices of products due to circulation channels has been avoided, and a brand image of high quality and low price has been established among hospitals and patients.

⑤Reduce the risk of infection and improve the quality and safety of medical services

At present, the rate of nosocomial infection control has become an important indicator in the hospital evaluation system. In the early stage, the products of some foreign disposable medical products companies relied on their close cooperation with medical staff around the world and full grasp of the diagnosis and treatment and surgical procedures, and through their disposable medical hygiene, Protective products reduce the risk of infection for medical staff and patients. However, higher prices of foreign products have led to increased medical costs. In China, cost control is an important factor that needs to be considered in the management of patients and hospitals. Especially in most of the relatively underdeveloped areas of China, it is impossible to popularize a full range of medical care in all aspects of clinical use through the large-scale application of disposable medical products. Anti-infection measures.

During the establishment of the issuer and for a long period of time thereafter, China’s medical consumables industry was mainly based on family-style and workshop-style production, which was characterized by low scale and technical level of manufacturers, uneven production qualifications, and relatively low production environment. Poor, product quality and after-sales service cannot be guaranteed, and the resulting national hospital infection rate and medical accidents have been at a high level. Nosocomial infections and complications not only affect the patient’s postoperative recovery and life safety, but also cause additional medical expenses for patients and the hospital, and bring huge economic burdens and waste of medical resources to patients and society. The concentrated outbreak of hospital infections may even cause Affect social stability. The control of hospital infection rates by hospitals and medical institutions at all levels has provided impetus for the growth of the disposable medical polymer products market.